中国保健营养(下旬刊)
中國保健營養(下旬刊)
중국보건영양(하순간)
CHINA HEALTH CARE & NUTRITION
2014年
1期
64-64,65
,共2页
海绵窦%脑膜瘤
海綿竇%腦膜瘤
해면두%뇌막류
Cavernous sinus%Meningioma
目的:目前对于海绵窦的脑膜瘤,手术切除仍然比较困难。方法在这项回顾性研究中,按照手术类型将2000年1月---2013年1月期间接受手术治疗的50例患者分为两组:A组为打开海绵窦的手术组,B组为未打开海绵窦的手术组。平均随访时间5年。结果术后早期致残率和术后的永久致残率在两组间存在显著差异,长期随访中,两组的复发及病变进展的发生率无统计学差异。只有接受术后放疗的患者(81.5%)的临床放射学表现稳定。结论控制肿瘤生长与保留神经功能是治疗海绵窦脑膜瘤的首要目标。全切肿瘤与次全切除肿瘤后行放疗疗效相同。
目的:目前對于海綿竇的腦膜瘤,手術切除仍然比較睏難。方法在這項迴顧性研究中,按照手術類型將2000年1月---2013年1月期間接受手術治療的50例患者分為兩組:A組為打開海綿竇的手術組,B組為未打開海綿竇的手術組。平均隨訪時間5年。結果術後早期緻殘率和術後的永久緻殘率在兩組間存在顯著差異,長期隨訪中,兩組的複髮及病變進展的髮生率無統計學差異。隻有接受術後放療的患者(81.5%)的臨床放射學錶現穩定。結論控製腫瘤生長與保留神經功能是治療海綿竇腦膜瘤的首要目標。全切腫瘤與次全切除腫瘤後行放療療效相同。
목적:목전대우해면두적뇌막류,수술절제잉연비교곤난。방법재저항회고성연구중,안조수술류형장2000년1월---2013년1월기간접수수술치료적50례환자분위량조:A조위타개해면두적수술조,B조위미타개해면두적수술조。평균수방시간5년。결과술후조기치잔솔화술후적영구치잔솔재량조간존재현저차이,장기수방중,량조적복발급병변진전적발생솔무통계학차이。지유접수술후방료적환자(81.5%)적림상방사학표현은정。결론공제종류생장여보류신경공능시치료해면두뇌막류적수요목표。전절종류여차전절제종류후행방료료효상동。
Objective Today,meningiomas with primary or,more commonly,secondary involvement of the cavernous sinus remain a surgical challenge.Currently,in-dications,timing,and multimodal treatments with surgery and radiotherapy represent the main topics of discussion concerning these lesions .Methods 50 patients under-went surgery between 2000 and 2013.The patients were retrospectively divided into 2 groups according to the type of surgical treatment:group A (open sinus surgery) and group B (closed sinus surgery).The mean follow -up time was 5 years.Results Early postoperative morbidity and permanent postoperative morbidity showed signi?cant differences between the groups.At long-term follow-up,we found no statistical differences in the incidence of recurrences and progressions .Only patients treated with postoperative radiation therapy (81.5%) showed clinic radiological stability.Conclusion Growth control and preservation of neurological functions are the primary goals in the treatment of cavernous sinus meningiomas.In most cases,surgery and radio surgery alone do not reach the primary goals,and unresolved issues remain.There-fore,we have developed a treatment algorithm as a guide to the best therapeutic options for the most common presentations of the disease .